Cargando…

Demonstration of protein-fragment complementation assay using purified firefly luciferase fragments

BACKGROUND: Human interactome is predicted to contain 150,000 to 300,000 protein-protein interactions, (PPIs). Protein-fragment complementation assay (PCA) is one of the most widely used methods to detect PPI, as well as Förster resonance energy transfer (FRET). To date, successful applications of f...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohmuro-Matsuyama, Yuki, Chung, Chan-I, Ueda, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3626928/
https://www.ncbi.nlm.nih.gov/pubmed/23536995
http://dx.doi.org/10.1186/1472-6750-13-31
_version_ 1782266272767016960
author Ohmuro-Matsuyama, Yuki
Chung, Chan-I
Ueda, Hiroshi
author_facet Ohmuro-Matsuyama, Yuki
Chung, Chan-I
Ueda, Hiroshi
author_sort Ohmuro-Matsuyama, Yuki
collection PubMed
description BACKGROUND: Human interactome is predicted to contain 150,000 to 300,000 protein-protein interactions, (PPIs). Protein-fragment complementation assay (PCA) is one of the most widely used methods to detect PPI, as well as Förster resonance energy transfer (FRET). To date, successful applications of firefly luciferase (Fluc)-based PCA have been reported in vivo, in cultured cells and in cell-free lysate, owing to its high sensitivity, high signal-to-background (S/B) ratio, and reversible response. Here we show the assay also works with purified proteins with unexpectedly rapid kinetics. RESULTS: Split Fluc fragments both fused with a rapamycin-dependently interacting protein pair were made and expressed in E. coli system, and purified to homogeneity. When the proteins were used for PCA to detect rapamycin-dependent PPI, they enabled a rapid detection (~1 s) of PPI with high S/B ratio. When Fn7-8 domains (7 nm in length) that was shown to abrogate GFP mutant-based FRET was inserted between split Fluc and FKBP12 as a rigid linker, it still showed some response, suggesting less limitation in interacting partner’s size. Finally, the stability of the probe was investigated. Preincubation of the probes at 37 degreeC up to 1 h showed marked decrease of the luminescent signal to 1.5%, showing the limited stability of this system. CONCLUSION: Fluc PCA using purified components will enable a rapid and handy detection of PPIs with high S/B ratio, avoiding the effects of concomitant components. Although the system might not be suitable for large-scale screening due to its limited stability, it can detect an interaction over larger distance than by FRET. This would be the first demonstration of Fluc PCA in vitro, which has a distinct advantage over other PPI assays. Our system enables detection of direct PPIs without risk of perturbation by PPI mediators in the complex cellular milieu.
format Online
Article
Text
id pubmed-3626928
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-36269282013-04-17 Demonstration of protein-fragment complementation assay using purified firefly luciferase fragments Ohmuro-Matsuyama, Yuki Chung, Chan-I Ueda, Hiroshi BMC Biotechnol Research Article BACKGROUND: Human interactome is predicted to contain 150,000 to 300,000 protein-protein interactions, (PPIs). Protein-fragment complementation assay (PCA) is one of the most widely used methods to detect PPI, as well as Förster resonance energy transfer (FRET). To date, successful applications of firefly luciferase (Fluc)-based PCA have been reported in vivo, in cultured cells and in cell-free lysate, owing to its high sensitivity, high signal-to-background (S/B) ratio, and reversible response. Here we show the assay also works with purified proteins with unexpectedly rapid kinetics. RESULTS: Split Fluc fragments both fused with a rapamycin-dependently interacting protein pair were made and expressed in E. coli system, and purified to homogeneity. When the proteins were used for PCA to detect rapamycin-dependent PPI, they enabled a rapid detection (~1 s) of PPI with high S/B ratio. When Fn7-8 domains (7 nm in length) that was shown to abrogate GFP mutant-based FRET was inserted between split Fluc and FKBP12 as a rigid linker, it still showed some response, suggesting less limitation in interacting partner’s size. Finally, the stability of the probe was investigated. Preincubation of the probes at 37 degreeC up to 1 h showed marked decrease of the luminescent signal to 1.5%, showing the limited stability of this system. CONCLUSION: Fluc PCA using purified components will enable a rapid and handy detection of PPIs with high S/B ratio, avoiding the effects of concomitant components. Although the system might not be suitable for large-scale screening due to its limited stability, it can detect an interaction over larger distance than by FRET. This would be the first demonstration of Fluc PCA in vitro, which has a distinct advantage over other PPI assays. Our system enables detection of direct PPIs without risk of perturbation by PPI mediators in the complex cellular milieu. BioMed Central 2013-03-28 /pmc/articles/PMC3626928/ /pubmed/23536995 http://dx.doi.org/10.1186/1472-6750-13-31 Text en Copyright © 2013 Ohmuro-Matsuyama et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Ohmuro-Matsuyama, Yuki
Chung, Chan-I
Ueda, Hiroshi
Demonstration of protein-fragment complementation assay using purified firefly luciferase fragments
title Demonstration of protein-fragment complementation assay using purified firefly luciferase fragments
title_full Demonstration of protein-fragment complementation assay using purified firefly luciferase fragments
title_fullStr Demonstration of protein-fragment complementation assay using purified firefly luciferase fragments
title_full_unstemmed Demonstration of protein-fragment complementation assay using purified firefly luciferase fragments
title_short Demonstration of protein-fragment complementation assay using purified firefly luciferase fragments
title_sort demonstration of protein-fragment complementation assay using purified firefly luciferase fragments
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3626928/
https://www.ncbi.nlm.nih.gov/pubmed/23536995
http://dx.doi.org/10.1186/1472-6750-13-31
work_keys_str_mv AT ohmuromatsuyamayuki demonstrationofproteinfragmentcomplementationassayusingpurifiedfireflyluciferasefragments
AT chungchani demonstrationofproteinfragmentcomplementationassayusingpurifiedfireflyluciferasefragments
AT uedahiroshi demonstrationofproteinfragmentcomplementationassayusingpurifiedfireflyluciferasefragments